Clinical Trial Update: Induced-T Cell Like NK Cells for B Cell Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for induced-T cell like NK cells targeting B cell malignancies is underway in Phase 1/Phase 2, with unspecified current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Leukemia
• B-cell Lymphoma
• B-cell Lymphoma Recurrent
• B-cell Lymphoma Refractory

Drugs mentioned

• induced-T cell like NK cells

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: B Cell Leukemia, B Cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN